Primary |
Product Used For Unknown Indication |
43.4% |
Depression |
19.0% |
Smoking Cessation Therapy |
7.0% |
Drug Use For Unknown Indication |
6.3% |
Major Depression |
4.4% |
Overdose |
3.4% |
Bipolar Disorder |
2.9% |
Polydipsia Psychogenic |
2.7% |
Chronic Obstructive Pulmonary Disease |
1.5% |
Hypertension |
1.5% |
Anxiety |
1.1% |
Antidepressant Therapy |
1.0% |
Attention Deficit/hyperactivity Disorder |
0.8% |
Depressive Symptom |
0.8% |
Ex-tobacco User |
0.8% |
Schizoaffective Disorder |
0.8% |
Sleep Disorder |
0.8% |
Toxicity To Various Agents |
0.8% |
Antiviral Treatment |
0.6% |
Drug Abuse |
0.6% |
|
Poisoning |
19.1% |
Product Substitution Issue |
10.0% |
Respiratory Arrest |
9.1% |
Drug Ineffective |
8.6% |
Suicidal Ideation |
7.7% |
Toxicity To Various Agents |
5.9% |
Tremor |
4.1% |
Unresponsive To Stimuli |
4.1% |
Vomiting |
4.1% |
Completed Suicide |
3.6% |
Convulsion |
3.2% |
Overdose |
3.2% |
Rash |
2.7% |
Headache |
2.3% |
Irritability |
2.3% |
Suicide Attempt |
2.3% |
Urticaria |
2.3% |
Intentional Drug Misuse |
1.8% |
Serotonin Syndrome |
1.8% |
Somnolence |
1.8% |
|
Secondary |
Product Used For Unknown Indication |
49.7% |
Depression |
9.0% |
Suicide Attempt |
8.8% |
Drug Use For Unknown Indication |
6.7% |
Smoking Cessation Therapy |
3.2% |
Anxiety |
2.7% |
Asthma |
2.2% |
Dyspepsia |
1.9% |
Post-traumatic Stress Disorder |
1.8% |
Migraine |
1.7% |
Intentional Drug Misuse |
1.5% |
Hypersensitivity |
1.5% |
Diabetes Mellitus |
1.4% |
Gastrooesophageal Reflux Disease |
1.3% |
Hypertension |
1.3% |
Major Depression |
1.3% |
Foetal Exposure During Pregnancy |
1.2% |
Bipolar Disorder |
1.1% |
Overdose |
0.9% |
Hepatitis C Virus Test Positive |
0.9% |
|
Completed Suicide |
29.8% |
Toxicity To Various Agents |
20.7% |
Respiratory Arrest |
9.4% |
Drug Abuse |
5.6% |
Tremor |
4.6% |
Poisoning |
4.3% |
Drug Toxicity |
4.1% |
Death |
2.6% |
Swelling Face |
2.0% |
Withdrawal Syndrome |
2.0% |
Overdose |
1.8% |
Weight Increased |
1.8% |
Intentional Drug Misuse |
1.5% |
Intentional Overdose |
1.5% |
Memory Impairment |
1.5% |
Sinus Tachycardia |
1.5% |
Cardiac Arrest |
1.3% |
Drug Hypersensitivity |
1.3% |
Unresponsive To Stimuli |
1.3% |
Vomiting |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
37.0% |
Depression |
14.4% |
Drug Use For Unknown Indication |
6.1% |
Pain |
5.6% |
Hypertension |
5.4% |
Anxiety |
4.4% |
Smoking Cessation Therapy |
3.2% |
Gastrooesophageal Reflux Disease |
2.8% |
Asthma |
2.4% |
Rheumatoid Arthritis |
2.3% |
Multiple Sclerosis |
2.0% |
Insomnia |
2.0% |
Bipolar Disorder |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Diabetes Mellitus |
1.7% |
Blood Cholesterol Increased |
1.4% |
Crohn's Disease |
1.4% |
Hepatitis C |
1.4% |
Fibromyalgia |
1.3% |
Back Pain |
1.3% |
|
Vomiting |
10.8% |
Weight Decreased |
10.1% |
Drug Ineffective |
6.7% |
Weight Increased |
6.7% |
Pain |
6.3% |
Pulmonary Embolism |
6.3% |
Nausea |
5.6% |
Tremor |
4.9% |
Pain In Extremity |
4.5% |
Injection Site Pain |
4.3% |
Vision Blurred |
4.3% |
Anxiety |
3.8% |
Somnolence |
3.6% |
Suicidal Ideation |
3.6% |
Paraesthesia |
3.4% |
Pneumonia |
3.1% |
Pruritus |
3.1% |
Wheezing |
3.1% |
Depression |
2.9% |
Fatigue |
2.9% |
|
Interacting |
Depression |
22.2% |
Major Depression |
22.2% |
Product Used For Unknown Indication |
20.4% |
Polydipsia Psychogenic |
14.8% |
Post-traumatic Stress Disorder |
7.4% |
Fibromyalgia |
3.7% |
Musculoskeletal Pain |
3.7% |
Hallucination, Auditory |
1.9% |
Hypothyroidism |
1.9% |
Pneumonia |
1.9% |
|
Suicidal Ideation |
22.2% |
Drug Interaction |
11.1% |
Hypersexuality |
11.1% |
Serotonin Syndrome |
11.1% |
Fatigue |
5.6% |
Heart Rate Irregular |
5.6% |
Hypersensitivity |
5.6% |
Polydipsia Psychogenic |
5.6% |
Somnolence |
5.6% |
Tearfulness |
5.6% |
Toxicity To Various Agents |
5.6% |
Tremor |
5.6% |
|